Bone marrow-derived cells for cardiovascular cell therapy: an optimized GMP method based on low-density gradient improves cell purity and function

BACKGROUND: Cardiovascular cell therapy represents a promising field, with several approaches currently being tested. The advanced therapy medicinal product (ATMP) for the ongoing METHOD clinical study (“Bone marrow derived cell therapy in the stable phase of chronic ischemic heart disease”) consist...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Radrizzani, Marina, Lo Cicero, Viviana, Soncin, Sabrina, Bolis, Sara, Sürder, Daniel, Torre, Tiziano, Siclari, Francesco, Moccetti, Tiziano, Vassalli, Giuseppe, Turchetto, Lucia
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2014
Gaiak:
Methodology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4189603/
https://ncbi.nlm.nih.gov/pubmed/25260977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-014-0276-0
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak